Tracking the course of substance-induced versus independent depression: diagnostic change upon follow-up?
Over three million Australians have a lifetime alcohol use disorder and one in five will have co-occurring major depression in the last year.
Over three million Australians have a lifetime alcohol use disorder and one in five will have co-occurring major depression in the last year.
The majority of buprenorphine-naloxone (Suboxone®) dosing in Australia involves supervised dosing of sublingual tablets in order to enhance medication adherence and to minimise aberrant behaviours such as diversion and/or injecting.
Despite its widespread use, relatively few cannabis users present to treatment, with only 31,980 episodes of care provided for primary cannabis use problems in 2006-07 (AIHW, 2008).
Despite its widespread use, relatively few cannabis users present to treatment, with only 31,980 episodes of care provided for primary cannabis use problems in 2006-07 (AIHW, 2008).
There is a growing body of research evidence demonstrating the impact of a range of pre-sentence diversion options at engaging substance misusing defendants in treatment, and reducing illicit drug use and ‘related’ offending in both Australian and British contexts.
In 2000, a national commitment has been made to expand access to antiretroviral (ARVs) in Vietnam. However, the number of patients infected with HIV in need of ARV has far exceeded the supply of ARVs. Little has been done on cost and effectiveness of antiretroviral treatment in Vietnam.
It is known that women experiencing homelessness are at high risk of unintended pregnancy (Gelberg 2007).
In recent years, there has been a focus on developing practice guidelines to facilitate the delivery of evidenced-based interventions.